GlassScriptPhysician profile
Saadia Zafar
NPI 1164626420
$666.95
in general payments reported to CMS, 2019-2025
12 companies · $186 in 2025
The $186 reported for 2025 was more than what 79% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.02 · 2020: $24.72 · 2021: $47.06 · 2022: $98.73 · 2023: $61.89 · 2024: $231 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $172.78 | 2024 | Airseal |
| Merck Sharp & Dohme LLC | $128.56 | 2019-2025 | Bridion |
| Lilly USA, LLC | $60.69 | 2025 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $56.10 | 2022-2025 | Dupixent |
| Heron Therapeutics, INC. | $46.78 | 2023-2024 | Aponvie |
| Csl Behring | $44.78 | 2021-2022 | |
| Janssen Biotech, INC. | $41.68 | 2025 | Tremfya |
| Qol Medical, LLC | $34.81 | 2024 | Sucraid |
| Abbvie INC. | $25.84 | 2022 | |
| Cerus Corporation | $23.62 | 2023 | Intercept Blood System For Platelets |
| Ambu INC. | $18.67 | 2022 | |
| Shionogi INC | $12.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saadia Zafar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.